CAMBRIDGE, Mass., Aug. 25, 2022 -- Aktis Oncology, a biotechnology company discovering and developing novel classes of targeted alpha radiopharmaceuticals to treat a broad range of solid tumors, today announced...
Sean McCarthy will participate on a panel at the BIO International Convention in San Diego, CA titled "New Models for External Innovation by Pharma"
News | 06. 17. 2008
